EP3319970 - PYRIDO-OXAZINONE DERIVATIVES AS TNAP INHIBITORS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 10.07.2020 Database last updated on 03.09.2024 | |
Former | The patent has been granted Status updated on 26.07.2019 | ||
Former | Grant of patent is intended Status updated on 12.03.2019 | ||
Former | Request for examination was made Status updated on 13.04.2018 | ||
Former | The international publication has been made Status updated on 13.01.2017 | ||
Former | unknown Status updated on 11.11.2016 | Most recent event Tooltip | 14.08.2020 | Change - lapse in a contracting state State(s) deleted from list of lapses: IS | published on 16.09.2020 [2020/38] | Applicant(s) | For all designated states Daiichi Sankyo Company, Limited 3-5-1, Nihonbashi Honcho Chuo-ku Tokyo 103-8426 / JP | For all designated states Sanford Burnham Prebys Medical Discovery Institute 10901 N. Torrey Pines Rd. La Jolla, CA 92037 / US | [2019/15] |
Former [2018/20] | For all designated states Daiichi Sankyo Company, Limited 3-5-1 Nihonbashi-honcho Chuo-ku Tokyo 103-8426 / JP | ||
For all designated states Sanford Burnham Prebys Medical Discovery Institute 10901 N. Torrey Pines Rd. La Jolla, CA 92037 / US | Inventor(s) | 01 /
MIYAZAKI, Shojiro c/o Daiichi Sankyo Company Limited 1-2-58 Hiromachi Shinagawa-ku Tokyo 140-8710 / JP | 02 /
YAMAMOTO, Yuko c/o Daiichi Sankyo Company Limited 1-2-58 Hiromachi Shinagawa-ku Tokyo 140-8710 / JP | 03 /
SUZUKI, Keisuke c/o Daiichi Sankyo Company Limited 1-2-58 Hiromachi Shinagawa-ku Tokyo 140-8710 / JP | 04 /
INUI, Masaharu c/o Daiichi Sankyo Company Limited 1-2-58 Hiromachi Shinagawa-ku Tokyo 140-8710 / JP | 05 /
IZUMI, Masanori c/o Daiichi Sankyo Company Limited 1-2-58 Hiromachi Shinagawa-ku Tokyo 140-8710 / JP | 06 /
SOMA, Kaori c/o Daiichi Sankyo Company Limited 1-2-58 Hiromachi Shinagawa-ku Tokyo 140-8710 / JP | 07 /
PINKERTON, Anthony c/o Sanford Burnham Prebys Medical Discovery Institute 10901 North Torrey Pines Road La Jolla, CA 92037 / US | 08 /
SHINOZAKI, Taeko c/o Daiichi Sankyo Company Limited 1-2-58 Hiromachi Shinagawa-ku Tokyo 140-8710 / JP | [2018/20] | Representative(s) | Wallace, Sheila Jane Marks & Clerk LLP 15 Fetter Lane London EC4A 1BW / GB | [2019/35] |
Former [2018/20] | Wallace, Sheila Jane Marks & Clerk LLP 90 Long Acre London WC2E 9RA / GB | Application number, filing date | 16775006.6 | 07.07.2016 | [2018/20] | WO2016US41345 | Priority number, date | US201562190145P | 08.07.2015 Original published format: US 201562190145 P | [2018/20] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2017007943 | Date: | 12.01.2017 | Language: | EN | [2017/02] | Type: | A1 Application with search report | No.: | EP3319970 | Date: | 16.05.2018 | Language: | EN | The application published by WIPO in one of the EPO official languages on 12.01.2017 takes the place of the publication of the European patent application. | [2018/20] | Type: | B1 Patent specification | No.: | EP3319970 | Date: | 28.08.2019 | Language: | EN | [2019/35] | Search report(s) | International search report - published on: | EP | 12.01.2017 | Classification | IPC: | C07D498/04, A61K31/4353, A61P19/00 | [2018/20] | CPC: |
C07D498/10 (EP,KR,RU,US);
C07D498/04 (EP,IL,KR,RU,US);
A61K31/553 (EP,KR,RU,US);
A61K9/20 (KR,US);
A61K9/48 (KR,US);
A61P19/00 (EP,KR,RU);
A61P19/02 (EP);
A61P19/04 (EP);
A61P35/00 (EP);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/20] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | MA | Not yet paid | MD | Not yet paid | Title | German: | PYRIDO-OXAZINONDERIVATE ALS TNAP-INHIBITOREN | [2018/20] | English: | PYRIDO-OXAZINONE DERIVATIVES AS TNAP INHIBITORS | [2018/20] | French: | DÉRIVÉS DE PYRIDO-OXAZINONE UTILISÉ COMME INHIBITEURS DE TNAP | [2018/20] | Entry into regional phase | 18.12.2017 | National basic fee paid | 18.12.2017 | Designation fee(s) paid | 18.12.2017 | Examination fee paid | Examination procedure | 18.12.2017 | Examination requested [2018/20] | 18.12.2017 | Date on which the examining division has become responsible | 01.10.2018 | Amendment by applicant (claims and/or description) | 13.03.2019 | Communication of intention to grant the patent | 18.07.2019 | Fee for grant paid | 18.07.2019 | Fee for publishing/printing paid | 18.07.2019 | Receipt of the translation of the claim(s) | Opposition(s) | 03.06.2020 | No opposition filed within time limit [2020/33] | Fees paid | Renewal fee | 11.07.2018 | Renewal fee patent year 03 | 15.07.2019 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | deleted | [2020/38] |
Former [2020/14] | IS | 28.12.2019 | Cited in | International search | [AD]WO2013126608 (SANFORD BURNHAM MED RES INST [US]) [AD] 1-22 * pages 1-2; example - *; | [AD] - DEBRAY JULIEN ET AL, "Inhibitors of tissue-nonspecific alkaline phosphatase: Design, synthesis, kinetics, biomineralization and cellular tests", BIOORGANIC & MEDICINAL CHEMISTRY, (2013), vol. 21, no. 24, doi:10.1016/J.BMC.2013.09.053, ISSN 0968-0896, pages 7981 - 7987, XP028796465 [AD] 1-22 * the whole document * DOI: http://dx.doi.org/10.1016/j.bmc.2013.09.053 | by applicant | WO2009017863 | WO2013126608 | US2015011551 | - J. BONE MINER RES, (2006), vol. 24, pages 176 - 181 | - CLIN. KIDERY. J., (2014), vol. 7, pages 167 - 173 | - EUR. HEART. J., (2014), vol. 35, pages 1515 - 1525 | - INT. J. NEPHROL. RENOVASC. DIS., (2014), vol. 7, pages 161 - 168 | - J. HISTOCHEM. CYTOCHEM., (2002), vol. 50, pages 333 - 340 | - J. AM. SOC. NEPHROL., (2004), vol. 15, pages 1392 - 1401 | - J. BONE MINER RES, (2013), vol. 7, pages 1587 - 1598 | - J. BONE MINER RES, (2007), vol. 22, pages 1700 - 1710 | - BIOORG. MED. CHEM. LETT., (2009), vol. 19, pages 222 - 225 | - J. MED. CHEM., (2009), vol. 52, pages 6919 - 6925 | - BIOORG. MED. CHEM., (2013), vol. 21, pages 7981 - 7897 | - J.BONE MINER RES, (2015), vol. 30, pages 824 - 836 | - Comprehensive Organic Transformations, Second Edition,, JOHN WILEY SONS, INC., (1999), pages 1978 - 1982 | - Comprehensive Organic Transformations, Fourth Edition,, JOHN WILEY SONS, INC., (1999), pages 821 - 828 | - A. P. DISHINGTON; P. D. JOHNSON; J. G. KETTLE, Tetrahedron Letters, (2004), vol. 45, page 3733 | - S. BHAGWANTH; A. G. WATERSON; G. M. ADJABENG; K. R. HORNBERGER, JOURNAL OF ORGANIC CHEMISTRY, (2009), vol. 74, page 4634 | - P. G. M. WUTS, Protective Groups in Organic Synthesis, Fourth Edition, JOHN WILEY SONS, INC., (2007), pages 725 - 735 | - X. WANG; A. GURAM; M. RONK; J. E. MILNE; J. S. TEDROW; M. M. FAUL, Tetrahedron Letters, (2012), vol. 53, page 7 | - W. DENG; L. LIU; C. ZHANG; M. LIU; Q.-X. GUO, TETRAHEDRON LETTERS, (2005), vol. 46, page 7295 | - D. K. LUCI; J. B. JAMESON; A. YASGAR; G. DIAZ; N. JOSHI; A. KANTZ; K. MARKHAM; S. PERRY; N. KUHN; J. YEUNG, JOURNAL OF MEDICINAL CHEMISTRY, (2014), vol. 57, page 495 |